Global Clinical Trials Matching Software Market (2022 to 2030) - Size, Share & Trends Analysis Report
May 30, 2022 07:58 ET
|
Research and Markets
Dublin, May 30, 2022 (GLOBE NEWSWIRE) -- The "Clinical Trials Matching Software Market Size, Share & Trends Analysis Report by Deployment Mode (Web & Cloud Based, On-premise), by End Use, by...
Insights on the Clinical Trials Site Management Organizations Global Market to 2030 - Increasing Rate of Clinical Trials Outsourcing by Companies is Driving Growth
May 30, 2022 07:53 ET
|
Research and Markets
Dublin, May 30, 2022 (GLOBE NEWSWIRE) -- The "Clinical Trials Site Management Organizations Market Size, Share & Trends Analysis Report by Clinical Trail Services/Components, by Phase, by...
The North American Clinical Trials Industry is Expected to Reach $39 Billion by 2031
May 30, 2022 04:43 ET
|
Research and Markets
Dublin, May 30, 2022 (GLOBE NEWSWIRE) -- The "North America Clinical Trials Market 2021-2031 by Product Category, Phase, Design, Service Type, Indication, End User, and Country: Trend Forecast and...
Outlook on the Clinical Trial Patient Recruitment Services Global Market to 2030 - Featuring Clara Health, BBK Worldwide and IQVIA Among Others
May 27, 2022 08:08 ET
|
Research and Markets
Dublin, May 27, 2022 (GLOBE NEWSWIRE) -- The "Clinical Trial Patient Recruitment Services Market Size, Share & Trends Analysis Report by Service Type, by Phase, by Therapeutic Areas (Respiratory...
Purple Biotech Presents Phase 1 Interim Monotherapy Data for NT219 at ASCO 2022, Demonstrating Encouraging Safety & Efficacy Profile
May 27, 2022 07:15 ET
|
Purple Biotech Ltd.
A Confirmed Partial Response in GEJ Patient, Stable Disease demonstrated in 75% of patients with mutated-KRAS colon cancer REHOVOT, Israel, May 27, 2022 (GLOBE NEWSWIRE) --...
SciSparc Announces Ethics Committee Approval to Conduct a Phase IIb Trial in Tourette Syndrome
May 26, 2022 08:30 ET
|
SciSparc Ltd
Ethics Committee approval received from the two sites that will conduct the SCI-110 trial in Germany and Israel TEL AVIV, Israel, May 26, 2022 (GLOBE NEWSWIRE) -- SciSparc Ltd. (NASDAQ: SPRC)...
POINT Biopharma to Participate in Upcoming Investor Conferences
May 19, 2022 17:30 ET
|
POINT Biopharma
INDIANAPOLIS, May 19, 2022 (GLOBE NEWSWIRE) -- POINT Biopharma Global Inc. (NASDAQ: PNT) (the “Company” or “POINT”), a company accelerating the discovery, development and global access to...
Inspirata Joins Advarra’s New API Partner Program as an Inaugural Member
May 18, 2022 09:00 ET
|
Inspirata, Inc.
Tampa, Florida, May 18, 2022 (GLOBE NEWSWIRE) -- Cancer informatics provider Inspirata announced today that it has become a member of the Advarra Partner Program. As an inaugural API Gold partner,...
Yseop’s AI-Powered Augmented Analyst Chosen by Lilly to Expedite the Drug Approval Process and Deploy Automation at Scale
May 18, 2022 08:00 ET
|
Yseop
NEW YORK, May 18, 2022 (GLOBE NEWSWIRE) -- Yseop, a world-leading AI software company and pioneer in Natural Language Processing (NLP), today announced a strategic collaboration with Eli Lilly and...
Immatics behandelt ersten Patienten mit ACTengine® TCR-T-Zelltherapie IMA203 in Kombination mit Checkpoint-Inhibitor Opdivo® (Nivolumab) in Patienten mit fortgeschrittenen soliden Tumoren
May 18, 2022 07:00 ET
|
Immatics N.V.
Die Phase-1b-Dosis-Expansionskohorte untersucht die Sicherheit, biologische Aktivität und erste Anzeichen einer Anti-Tumor-Aktivität der IMA203 TCR-T-Zelltherapie gegen die Zielstruktur PRAME in...